Enliven Therapeutics shares owned by J. Goldman & Co
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by J. Goldman & Co
from 13F filings
Historical chart of J. Goldman & Co investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by J. Goldman & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.1M | 29k | 39.20 |